Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06902285 · ClinicalTrials.gov registry record · Phase 4
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
A Phase 4 study of Sleep and Knee Osteoarthritis, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06902285: Recruiting Phase 4 study of Sleep and Knee Osteoarthritis, sponsored by University of Miami.
NCT06902285 is a Phase 4 study of Sleep and Knee Osteoarthritis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 64 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06902285, a Phase 4 study of Sleep and Knee Osteoarthritis, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery
Primary Outcome
Score ranging from 0-24 with higher scores indicating greater sleepiness.
Conditions Studied
Interventions
- OTHER Control
- DRUG Magnesium Threonate
Study Locations (1)
Florida
- University of Miami Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2026-05-01 |
| Phase | Phase 4 |
What NCT06902285 shows while recruiting
NCT06902285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06902285 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06902285 about?
NCT06902285 is a clinical study titled "Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty". The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery
What is the current status of trial NCT06902285?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2025-04-21. Estimated completion is 2026-05-01.
What conditions does trial NCT06902285 study?
This clinical trial studies the following conditions: Sleep, Knee Osteoarthritis.
What interventions are being tested in trial NCT06902285?
The interventions under investigation include: Control (OTHER), Magnesium Threonate (DRUG).
Who is sponsoring clinical trial NCT06902285?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06902285 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06902285's enrollment target sits among peer trials
64 89th of 151 higher than 63 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
-
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
COMPLETED · Phase 4
-
Hypnotic Medications and Memory: Effect of Drug Exposure During the Night
COMPLETED · Phase 4
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Research Framework Exploring Sleep Health
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI